---
title: "Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282099218.md"
description: "Bio-Techne Corp. (TECH) shares rose 2.56% to $55.21 on Wednesday, marking its third consecutive day of gains. However, the stock underperformed compared to competitors like Amgen Inc. (AMGN), which increased by 2.89%, and Charles River Laboratories (CRL), which rose by 3.26%. Bio-Techne remains 23.49% below its 52-week high of $72.16, reached on January 22nd. The overall market saw gains, with the S&P 500 up 2.51% and the Dow Jones up 2.85%."
datetime: "2026-04-08T21:16:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282099218.md)
  - [en](https://longbridge.com/en/news/282099218.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282099218.md)
---

# Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bio-Techne Corp. (TECH) advanced 2.56% to $55.21 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 2.51% to 6,782.81 and the Dow Jones Industrial Average rising 2.85% to 47,909.92.

This was the stock's third consecutive day of gains.

Bio-Techne Corp. closed 23.49% short of its 52-week high of $72.16, which the company achieved on January 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. (AMGN) rose 2.89% to $349.81, Charles River Laboratories International Inc. (CRL) rose 3.26% to $175.07, and BioMarin Pharmaceutical Inc. (BMRN) rose 1.74% to $57.20.

Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

04-08-26 1716ET

### Related Stocks

- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)

## Related News & Research

- [4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis](https://longbridge.com/en/news/283601589.md)
- [Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors](https://longbridge.com/en/news/284646666.md)
- [Stocks in Play: Oncolytics Biotech Inc](https://longbridge.com/en/news/284230718.md)
- [John B. Sanfilippo & Son, Inc. Reports Fiscal 2026 Third Quarter Results | JBSS Stock News](https://longbridge.com/en/news/284635568.md)
- [37,800 Shares in Neurocrine Biosciences, Inc. $NBIX Bought by Gray Foundation](https://longbridge.com/en/news/284204276.md)